Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1985 Nov;86(3):557–563. doi: 10.1111/j.1476-5381.1985.tb08931.x

Sex and hormonal influences on platelet sensitivity and coagulation in the rat.

H Emms, G P Lewis
PMCID: PMC1916735  PMID: 4063582

Abstract

Platelet sensitivity to adenosine di-phosphate (ADP), thrombin, collagen, arachidonic acid and prostaglandin I2 (PGI2) and the activity of the coagulation system as measured by the activated partial thromboplastin time, prothrombin time, Russell's viper venom time and plasma fibrinogen have been examined in male and female rats, female rats during the oestrous cycle and female rats treated with oestrogen and a progestogen. Male rat platelets were less sensitive to thrombin and more sensitive to inhibition by PGI2 than those from females and fibrinogen levels in male rat plasma were approximately twice those seen in females. During the oestrous cycle, platelets were more sensitive to ADP and less sensitive to thrombin at dioestrus. Following 6 weeks treatment with 17 beta-oestradiol or ethynyl oestradiol, both platelet aggregation and release of granular ATP induced by collagen were significantly reduced. Platelet sensitivity to other agents, ADP, arachidonic acid, thrombin and PGI2 was, however, unchanged following oestrogen treatment. Activation of factor X by Russell's viper venom was accelerated in rats treated with ethynyl oestradiol, although this enhancement was not reflected in the overall clotting times.

Full text

PDF
557

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brakman P., Albrechtsen O. K., Astrup T. A comparative study of coagulation and fibrinolysis in blood from normal men and women. Br J Haematol. 1966 Jan;12(1):74–85. doi: 10.1111/j.1365-2141.1966.tb00129.x. [DOI] [PubMed] [Google Scholar]
  2. Butcher R. L., Collins W. E., Fugo N. W. Plasma concentration of LH, FSH, prolactin, progesterone and estradiol-17beta throughout the 4-day estrous cycle of the rat. Endocrinology. 1974 Jun;94(6):1704–1708. doi: 10.1210/endo-94-6-1704. [DOI] [PubMed] [Google Scholar]
  3. Dodds W. J., Pickering R. J. The effect of cobra venom factor on hemostasis in guinea pigs. Blood. 1972 Sep;40(3):400–411. [PubMed] [Google Scholar]
  4. Dodds W. J., Raymond S. L., Moynihan A. C., Pickering R. J., Amiraian K. Coagulation studies in C4-deficient guinea pigs. Proc Soc Exp Biol Med. 1977 Mar;154(3):382–385. doi: 10.3181/00379727-154-39676. [DOI] [PubMed] [Google Scholar]
  5. Emms H., Lewis G. P. The effect of synthetic ovarian hormones on an in vivo model of thrombosis in the rat. Br J Pharmacol. 1985 Jan;84(1):243–248. [PMC free article] [PubMed] [Google Scholar]
  6. GOODWIN J. F. Estimation of plasma fibrinogen, using sodium sulfite fractionation. Am J Clin Pathol. 1961 Mar;35:227–232. doi: 10.1093/ajcp/35.3.227. [DOI] [PubMed] [Google Scholar]
  7. Henderson S. R., Baker C., Fink G. Oestradiol-17beta and pituitary responsiveness to luteinizing hormone releasing factor in the rat: a study using rectangular pulses of oestradiol-17beta monitored by non-chromatographic radioimmunoassay. J Endocrinol. 1977 Jun;73(3):441–453. doi: 10.1677/joe.0.0730441. [DOI] [PubMed] [Google Scholar]
  8. Johnson M., Ramey E., Ramwell P. W. Sex and age differences in human platelet aggregation. Nature. 1975 Jan 31;253(5490):355–357. doi: 10.1038/253355a0. [DOI] [PubMed] [Google Scholar]
  9. Pasqualini J. R., Castellet R., Portois M. C., Hill J. L., Kincl F. A. Plasma concentrations of ethynyl oestradiol and norethindrone after oral administration to women. J Reprod Fertil. 1977 Mar;49(2):189–193. doi: 10.1530/jrf.0.0490189. [DOI] [PubMed] [Google Scholar]
  10. Poller L. Oral contraceptives, blood clotting and thrombosis. Br Med Bull. 1978 May;34(2):151–156. doi: 10.1093/oxfordjournals.bmb.a071485. [DOI] [PubMed] [Google Scholar]
  11. RATNOFF O. D., MENZIE C. A new method for the determination of fibrinogen in small samples of plasma. J Lab Clin Med. 1951 Feb;37(2):316–320. [PubMed] [Google Scholar]
  12. Raymond S. L., Dodds W. J. Characterization of the fawn-hooded rat as a model for hemostatic studies. Thromb Diath Haemorrh. 1975 Apr 30;33(2):361–369. [PubMed] [Google Scholar]
  13. Scully M. F., Kakkar V. V. Methods for semi micro or automated determination of thrombin, antithrombin, and heparin cofactor using he substrate, H-D-Phe-Pip-Arg-p-nitroanilide-2HCl. Clin Chim Acta. 1977 Sep 15;79(3):595–602. doi: 10.1016/0009-8981(77)90181-4. [DOI] [PubMed] [Google Scholar]
  14. Thaler E., Lechner K. Antithrombin III deficiency and thromboembolism. Clin Haematol. 1981 Jun;10(2):369–390. [PubMed] [Google Scholar]
  15. Wilhelmsen L., Svärdsudd K., Korsan-Bengtsen K., Larsson B., Welin L., Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984 Aug 23;311(8):501–505. doi: 10.1056/NEJM198408233110804. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES